Navigation Links
Federal Court Appoints Girard Gibbs LLP Partner to Plaintiffs' Steering Committee in the Consolidated Yasmin and Yaz Lawsuits
Date:11/13/2009

A.J. De Bartolomeo, a partner at Girard Gibbs LLP, was appointed to the Plaintiffs' Steering Committee in the consolidated Yasmin and Yaz birth control litigation.

San Francisco, CA (PRWEB) November 13, 2009 -- The law firms of Girard Gibbs LLP and The Danko Law Firm are pleased to announce that Ms. A. J. De Bartolomeo, a partner with Girard Gibbs LLP, has been appointed to the Plaintiffs’ Steering Committee for the prosecution of the Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100), pending in the United States District Court for the Southern District of Illinois.

In an order issued by the Court on November 10, 2009, Chief U.S. District Judge David Herndon appointed A. J. De Bartolomeo to the 10-lawyer Plaintiffs’ Steering Committee, which will be responsible for conducting and coordinating pretrial proceedings in the litigation. Along with the other committee members, Ms. De Bartolomeo will serve as a spokesperson for all plaintiffs at pretrial proceedings and in response to any inquiries by the Court.

“I am pleased to be working with such an esteemed group of attorneys and believe that our collective experience in litigating important cases such as these will be of great service to the women and families injured by Yaz. As one of two women appointed to the Plaintiffs’ Steering Committee, I recognize the significance of this litigation, not only from a public health perspective, but also to women’s rights as a whole. We believe that people are entitled to be fully informed about the potential risks and health consequences of the medications that they take,” said Ms. De Bartolomeo.

More than 100 lawsuits have been filed throughout the United States by women who have suffered serious injuries after taking Yaz and Yasmin. On October 1, 2009, all of the Yaz and Yasmin lawsuits pending in federal court were consolidated and coordinated for pre-trial proceedings before Judge Herndon in the United States District Court for the Southern District of Illinois. The coordinated case, MDL No. 2100, is known as In Re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation.

“Our law firms speak with women every day who have suffered serious injuries after taking Yaz and Yasmin. Through this MDL litigation, we intend to prove that Bayer knew or should have known of the serious health risks Yasmin and Yaz presented, yet it failed to tell women that taking Yaz or Yasmin put them at a greater risk of developing severe health problems than with other oral contraceptives,” said Ms. De Bartolomeo.

Yaz and Yasmin are two of the most popular birth control pills in the United States and the top-selling products for Bayer Pharmaceuticals. These birth control pills contain a unique progestin hormone known as drospirenone, or “drsp,” which recent medical studies have found may increase the risk of thrombosis (a medical term for blood clots). The FDA has also stated that the use of drospirenone in these medications ‘may result in potentially serious heart and health problems.’ Yaz and Yasmin have also been the subject of three FDA Warning Letters for misleading advertising, which the FDA found minimized the risks of these drugs while promoting Yaz for conditions other than what it had been approved to treat.

Ms. De Bartolomeo will serve on the 10 member Steering Committee along with other distinguished attorneys appointed by the Court.

For more information, please contact Girard Gibbs LLP (www.girardgibbs.com/yazlawyers.asp) and The Danko Law Firm (www.dankolaw.com) , visit our blog www.YazOnTrial.com, or call 866-981-4800. Girard Gibbs LLP is one of the nation’s leading firms in prosecuting complex litigation cases including class and mass action cases. The Danko Law firm is a leading Northern California plaintiff’s personal injury firm.

# # #

Read the full story at http://www.prweb.com/releases/2009/11/prweb3202724.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MDMA Names New Director of Federal Affairs
2. Federal research plan to determine nanotech risks fails to deliver
3. Federal Employee Program Maintains Low Health Premiums In 2008
4. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
5. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
6. ACM Helps Medicaid Programs Comply With Federal Deficit Reduction Act Mandates
7. Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid
8. HIV/AIDS Cases Among State and Federal Prison Inmates Fell for the Sixth Straight Year During 2005
9. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
10. Federal Trade Commission Attempts To Suppress Best-Selling Authors First Amendment Rights
11. CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Federal Court Appoints Girard Gibbs LLP Partner to Plaintiffs' Steering Committee in the Consolidated Yasmin and Yaz Lawsuits 
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 ... , and OptiMed Specialty Pharmacy of Kalamazoo, ... offer a strategic hub service that expedites and streamlines ... personal spirometer, Spiro PD 2.0, and wellness management services.  ... is a medical device used to measure lung function ...
Breaking Medicine Technology: